Wickham Micro, a group laboratory of Cormica and a provider of microbiology contract testing services for medical devices and pharmaceutical manufacturers, has expanded its MALDI-ToF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) testing capabilities. 

By adding a new MALDI-ToF instrument to its laboratory in Gosport, Hampshire, the company has increased its capacity for microbial identification testing.

As the medical device and pharmaceutical industries evolve, so does the need for quicker and more precise microbial identification. MALDI-ToF technology is increasingly recognised as the one of the highest standards for these critical tasks, essential for ensuring product safety, efficacy, and regulatory compliance. Wickham Micro’s enhanced capacity is designed to meet this rising demand, offering clients a robust, reliable service that aligns with their production and release schedules.

Jennifer Bannatyne, MALDI-ToF Expert at Wickham Micro said: “The addition of our new MALDI-ToF instrument is more than just an expansion; it's a significant stride toward enhancing the reliability and speed of microbial identification for our clients. As well as increased capacity for Bacterial Identifications and the reduced chance of downtime due to servicing requirements, the additional Maldi-ToF unit will give us capacity to work on additional techniques such as identification of moulds by Maldi-ToF. With the aim to have implemented this service prior to 2024.

“In an industry where time and accuracy are not just requirements but imperatives, our increased capacity aligns perfectly with Wickham Micro's mission to deliver quality, reliability, and swift market entry for life-saving products. Our commitment to technology and science-based insights empowers us to be at the forefront of innovative testing solutions.”